DETROIT — Rookie sensation Nolan McLean demonstrated again on Tuesday that he’s capable of leading the New York Mets’ starting rotation through September and beyond, if they’re playing in the ...
HOUSTON--(BUSINESS WIRE)--Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...
Abstract: Rate-splitting multiple access (RSMA) emerges as a promising beyond 5G (B5G) network technology for ultrareliable low-latency communication (URLLC). It splits messages into private and ...
The FDA on Wednesday granted accelerated approval to linvoseltamab (Lynozyfic) for relapsed or refractory multiple myeloma after at least four prior lines of therapy. A B-cell maturation antigen (BCMA ...
A comparative analysis of outcomes following autologous hematopoietic cell transplantation in multiple myeloma patients with CRAB versus SLiM features. This is an ASCO Meeting Abstract from the 2025 ...
HONOLULU (KHON2) — Cell phone use in schools has been the subject of critical discussion across the country, and now the Hawaii Department of Education is asking for the opinions of parents, students, ...
LEE’S SUMMIT, Mo. (KCTV) - As the debate over student use of cell phones in school heats up nationwide, one local school district is getting input well ahead of any attempt at policy change. About 60 ...
The news that Patti Scialfa, Bruce Springsteen’s wife and bandmate, has multiple myeloma is bringing attention to the rare blood cancer. In the new documentary “Road Diary: Bruce Springsteen and the E ...
Three years after the first FDA approval of CAR-T cell therapy, patients with multiple myeloma are starting to see the therapy emerge in earlier lines. An innovative and groundbreaking cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback